Trademark Overview
On Wednesday, June 25, 2025, a trademark application was filed for OBRION with the United States Patent and Trademark Office. The USPTO has given the OBRION trademark a serial number of 99252545. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 10, 2026. This trademark is owned by OBI PHARMA, INC.. The OBRION trademark is filed in the Pharmaceutical Products category with the following description:
Immunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorga...
